Nutriband Inc. Watch

from POS AM 5 pages 1. References. Each Reference to “Hereof”, “Herein”, “Hereunder”, “Hereby” and “This Agreement” Shall From and After the Date of This Amendment Refer to the Agreement as Amended by This Amendment. Notwithstanding the Foregoing, References to the Date of the Agreement, as Amended Hereby, Shall in All Instances Continue to Refer to January 4, 2024, and References to the “The Date Hereof” and “The Date of This Agreement” Shall Continue to Refer to January 4, 2024. 2. Section 6.1 of the Agreement Is Hereby Deleted in Its Entirety and Replaced With the Following: 3. the Supply Price Section of Exhibit C Is Hereby Deleted in Its Entirety and Replaced With the Following: “Supply Price 4. a New Paragraph Defining Total Manufacturing Cost Shall Be Hereby Added to Exhibit C - Heads of Terms for Supply Agreement: “Total Manufacturing Cost 5. a New Paragraph Defining Indirect Costs Shall Be Hereby Added to Exhibit C- Heads of Terms for Supply Agreement

from POS AM 24 pages Commercial Development and Clinical Supply Agreement

from 10-K 5 pages Amendment No. 1, Dated as of February 4, 2025 (This “Amendment”), to the Commercial Development and Clinical Supply Agreement, Made as of January 4, 2024 (The “Agreement”), Is by and Between Kindeva Drug Delivery LP., a Delaware Limited Partnership With Principal Address at 11200 Hudson Road, Woodbury, Mn 55129 (“Kindeva”) and 4p Therapeutics LLC, a Delaware Limited Liability Company With Principal Address at P.O. Box 921031, Peachtree Corners, Ga 30010-1031 (“4p”). Capitalized Terms Used but Not Otherwise Defined Herein Shall Have the Meanings Ascribed to Such Terms in the Agreement. Whereas, Kindeva and 4p Are Parties to the Commercial Development and Clinical Supply Agreement Executed January 4, 2024 (The “Agreement”); Whereas, the Parties Wish to Establish New Commercial Supply Pricing; . Now, Therefore, in Consideration of the Mutual Covenants and Agreements Contained in This Amendment, and Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, and Intending to Be Legally Bound Hereby, the Parties Hereto Agree as Follows

from 10-K 25 pages Commercial Development and Clinical Supply Agreement

from 8-K/A 4 pages Amendment to Note Conversion Agreement Dated: May 22, 2024

from 8-K 4 pages Note Conversion Agreement Dated: May 14, 2024

from 8-K 13 pages Nutriband Inc. Subscription Agreement

from 8-K 4 pages Note Conversion Agreement

from 8-K 17 pages Employment Agreement Nutriband Inc

from 8-K 18 pages Employment Agreement Nutriband Inc

from 8-K 20 pages Employment Agreement Nutriband Inc

from S-8 7 pages Nutriband Inc. 2021 Employee Stock Option Plan Option Award Agreement

from S-8 8 pages Nutriband Inc. 2021 Employee Stock Option Plan

from 8-K 11 pages Active Intelligence, LLC Services Agreement

from 8-K 2 pages Amendment No. 1 to Purchase Agreement and Promissory Note

from 8-K 18 pages 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

from 8-K 8 pages Distribution Agreement, Dated March 26, 2021, Between the Company and Bpm Inno Ltd

from 8-K 22 pages License Agreement, Dated December 9, 2020, Between the Company and Rambam Med-Tech Ltd

from 8-K 4 pages Nutriband Inc. Promissory Note

from 8-K 8 pages Security Agreement